During the past decade, Centrum Onkologii Instytut im. Marii Sklodowskiej-Curie, Oddzial w Gliwicach conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 10 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 8 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centrum Onkologii Instytut im. Marii Sklodowskiej-Curie, Oddzial w Gliwicach" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored, "Eisai Inc." with 2 trials sponsored, "Ipsen" with 2 trials sponsored and "Astellas Pharma Inc" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Onkologii Instytut im. Marii Sklodowskiej-Curie, Oddzial w Gliwicach" #1 collaborator was "Merck Sharp & Dohme LLC" with 3 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "BeiGene" with 1 trials as a collaborator, "Eisai Europe Ltd. (United Kingdom)" with 1 trials as a collaborator and "GORTEC (Head and Neck Oncology and Radiotherapy Group)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Centrum Onkologii Instytut im. Marii Sklodowskiej-Curie, Oddzial w Gliwicach" are "Breast Neoplasms" (2 trials), "Multiple Myeloma" (2 trials), "Ovarian Cancer" (2 trials), "Adrenocortical Carcinoma" (1 trials) and "BRCA 1 Gene Mutation" (1 trials). Many other conditions were trialed in "Centrum Onkologii Instytut im. Marii Sklodowskiej-Curie, Oddzial w Gliwicach" in a lesser frequency.

Most popular intervention types in "Centrum Onkologii Instytut im. Marii Sklodowskiej-Curie, Oddzial w Gliwicach" are "Drug" (21 trials), "Device" (2 trials), "Other" (2 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Dexamethasone" (3 trials), "Gemcitabine" (3 trials), "Bendamustine" (2 trials) and "Bortezomib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centrum Onkologii Instytut im. Marii Sklodowskiej-Curie, Oddzial w Gliwicach" are 19 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Centrum Onkologii Instytut im. Marii Sklodowskiej-Curie, Oddzial w Gliwicach". undefined are not yet recruiting, 2 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Centrum Onkologii Instytut im. Marii Sklodowskiej-Curie, Oddzial w Gliwicach, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Centrum Onkologii Instytut im. Marii Sklodowskiej-Curie, Oddzial w Gliwicach, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Centrum Onkologii Instytut im. Marii Sklodowskiej-Curie, Oddzial w Gliwicach has several departments that took part in Clinical trials: "Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology Gliwice Branch" - 10 trials, "Klinika Transplantacji Szpiku i Onkohematologii Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie Państwowy Instytut Badawczy, Oddział w Gliwicach" - 7 trials, "Narodowy Instytut Onkologii Odział w Gliwicach; Centrum Diagnostyki i Leczenia Chorób Piersi" - 3 trials